Puma SE
OTC:PMMAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma SE
OTC:PMMAF
|
DE |
|
Universal Technical Institute Inc
NYSE:UTI
|
US |
|
S
|
Schlumberger NV
XBER:SCL
|
US |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
|
Komeda Holdings Co Ltd
TSE:3543
|
JP |
|
U
|
United Therapeutics Corp
F:UTH
|
US |
|
K
|
Kikkoman Corp
DUS:KIK
|
JP |
|
A
|
Argan Inc
F:1AW
|
US |
Wall St Price Targets
PMMAF Price Targets Summary
Puma SE
According to Wall Street analysts, the average 1-year price target for PMMAF is 31.94 USD with a low forecast of 20.8 USD and a high forecast of 48.06 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PMMAF's stock price target?
Price Target
31.94
USD
According to Wall Street analysts, the average 1-year price target for PMMAF is 31.94 USD with a low forecast of 20.8 USD and a high forecast of 48.06 USD.
What is the Revenue forecast for Puma SE?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Puma SE?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 5%.
